ArticleJournal of gastrointestinal oncology2022

The bevacizumab plus oxaliplatin-based chemotherapy regimen is more suitable for metastatic colorectal cancer patients with a history of schistosomiasis: a clinical retrospective analysis.

Li-Na Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.